Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia



Status:Completed
Conditions:Postherpatic Neuralgia
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:3/30/2013
Start Date:October 2012
End Date:October 2013
Contact:Pfizer CT.gov Call Center
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

A Phase 4 Multicenter, Open-Label, Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia


The primary objective is to explore whether sensory symptom cluster analysis is useful for
predicting treatment response in Postherpetic Neuralgia.


Inclusion Criteria:

- Subjects must have pain present for more than 3 months after the healing of the
herpes zoster skin rash.

- At screening (V1) and baseline (V2), subjects must have a score of >=4 on the Numeric
Rating Scale for Pain (1 week recall period).

- At baseline (V2), at least 4 pain diaries must be completed satisfactorily within the
last 7 days and the average pain score must be >=4.

Exclusion Criteria:

- Subjects having other severe pain that may confound assessment or self evaluation of
the pain due to PHN.

- Neurolytic or neurosurgical therapy for Postherpetic Neuralgia

- Skin conditions in the affected dermatome that could alter sensation.
We found this trial at
7
sites
Asheville, North Carolina 28801
?
mi
from
Asheville, NC
Click here to add this to my saved trials
Akron, Ohio 44314
?
mi
from
Akron, OH
Click here to add this to my saved trials
Ashland, Kentucky 41101
?
mi
from
Ashland, KY
Click here to add this to my saved trials
Ashland, Oregon 97520
?
mi
from
Ashland, OR
Click here to add this to my saved trials
Atlantis, Florida 33462
?
mi
from
Atlantis, FL
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15212
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials